tag

The new intake of medical students at Weill Cornell Medicine-Qatar (WCM-Q) have marked the beginning of their training by donning the white coat of the physician for the first time at a special ceremony.Each of the new medical students received their white coat and their first stethoscope at the Opening Exercises ceremony, a symbolic event that marks the point when students begin the four-year medical curriculum that will eventually lead to them graduating as doctors. This year there are 57 students enrolled on the first year of the medical curriculum.Of the 57 first-year students, 26 are men and 31 are women. Nineteen of the cohort are Qatari nationals. If successful in their studies, each student will be awarded the Cornell University MD degree.Dean of WCM-Q Dr. Javaid Sheikh said: "Pulling on the white coat of the physician for the first time is an important milestone in the career of any doctor, marking the point at which they take their first steps into a profession that demands technical excellence, compassion, and dedication. All of us at WCM-Q have great confidence the members of this cohort will excel and go on to become the next generation of leaders in medical science and innovation, driving our profession forwards into a bright future of enhanced patient care."The keynote address at the event was given by WCM-Q alumna Dr. Noor Al Khori, now senior attending physician at Sidra Medicine. Dr. Al Khori said: "As you feel the fabric slip onto your shoulders today, feel its magic. Feel the weight of the trust that is placed in you. Feel the weight of history. But also, feel the excitement of the adventures to come. Your white coat is a flag - a flag of humanity, of compassion, and of unwavering principle. It is a banner you raise for every patient, in every circumstance, declaring that here, in your care, dignity and kindness will prevail."

Sidra Medicine, a member of Qatar Foundation, has signed a memorandum of understanding (MoU) with QIIB to explore collaborative pathways that will broaden access to services and create business development opportunities.The MoU was signed between Dr Iyabo Tinubu-Karch, Chief Executive Officer of Sidra Medicine and Dr Abdulbasit Ahmad al-Shaibei, Chief Executive Officer of QIIB. Tinubu-Karch said: “The MoU with QIIB is a testament to Sidra Medicine’s commitment to improving our service delivery model and securing new and innovative ways of providing access to care as well as expanding our brand presence in Qatar.This also highlights our mutual goal to establish partnerships that extends the reach of the banking sector to patient communities.” QIIB is a privately owned Islamic bank in Qatar that offers personal and corporate Islamic banking solutions.The MoU with Sidra Medicine will also seek to establish new access points for patients including healthcare financing options. Dr al-Shaibei stated: “We are pleased at QIIB to sign this memorandum of understanding with Sidra Medicine, which we consider an important milestone in strengthening co-operation with a leading medical institution of distinguished reputation. “We hope that this partnership will contribute to providing innovative solutions that offer patients broader options and support the sustainability of medical services.This collaboration also reflects our commitment to our social role and our drive to build strategic partnerships that align with the Qatar National Vision 2030 and promote comprehensive development.” He added: “At QIIB, we place our commitment to society at the core of our strategy, ensuring that our initiatives are aligned with the Third Financial Sector Strategic Plan launched by the Qatar Central Bank, which places strong emphasis on sustainability and financial inclusion. Through such partnerships, we reaffirm our role in supporting the national economy and contributing to the achievement of sustainable development goals, with positive impact on both individuals and the wider community.”

Four students from Weill Cornell Medicine–Qatar (WCM-Q) are named as joint first co-authors on a perspective paper proposing microbiome-based solutions to combat antimicrobial resistance (AMR).They were guided by their supervisor, Dr Ghizlane Bendriss, assistant professor of biology at WCM-Q, who is the lead author of the paper. The paper has been published in Frontiers in Microbiomes, a leading scientific journal.Students Ali al-Kuwari, Hamad al-Karbi, Abdulla al-Khuzaei and Dounia Baroudi conducted the study in response to an announcement at the 7th edition of the World Innovation Summit for Health, held in November 2024, which emphasised that tackling AMR was a national priority.The perspective paper discusses several strategies to address the loss of diversity caused by antibiotics, including diet, probiotics, fecal transplants (FMT), and the fermentation of animal and plant products.Preliminary findings from an experiment with camel milk fermentation suggest that fermentation increases microbial diversity, enhances microbiome resilience, and potentially reduces resistance to common antibiotics like tetracycline, streptomycin, penicillin, and chloramphenicol.The increase of diversity allows the microbiome to naturally resist pathogens without additional antibiotic use.Dr Bendriss said: “Over the past four decades, antibiotic innovation and approvals have sharply declined, with annual FDA approvals dropping from about three in the 1980s to barely one today, the share of new antibiotics falling from 20% to 6% of drug approvals, and almost no truly new classes emerging since the mid-20th century.To effectively address AMR, we really need to completely shift our strategy. Microbes already possess a natural ability to fight one another by competing for nutrients and by producing antimicrobial metabolites.Therefore, I believe that microbiome-based solutions such as probiotics or FMT can offer the most sustainable alternative to traditional pharmaceutical interventions.”Additionally, the paper discusses a mechanistic model to underscore the importance of maintaining microbial balance as an effective strategy for mitigating AMR and promoting long-term health.Further research is, however, still needed to better understand the mechanisms behind these changes and their implications for public health.Student al-Kuwari said: “This project deepened my understanding of the microbial world and introduced me to the boundless potential of microbiome-based approaches in tackling real-world health challenges.With antimicrobial resistance becoming an increasingly urgent global concern, contributing to research that explores innovative, targeted solutions has been both timely and meaningful.”Fellow student Baroudi said: “Through this research, I realised that fighting harmful bacteria isn’t just about using more antibiotics; sometimes, it’s about finding better ways to restore and encourage a healthy balance of microbes.This research focuses on identifying sustainable approaches, like fermentation and restoring microbial balance, as innovative ways to nurture microbial ecosystems and offer new hope against the growing problem of antibiotic resistance.”